poloxalene has been researched along with Acute Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerqueira, MD; Hallstrom, AP; Martin, JS; Maynard, C; Paris, JA; Swenson, R; Weaver, WD | 1 |
2 trial(s) available for poloxalene and Acute Kidney Failure
| Article | Year |
|---|---|
Effects of RheothRx on mortality, morbidity, left ventricular function, and infarct size in patients with acute myocardial infarction. Collaborative Organization for RheothRx Evaluation (CORE).
Topics: Acute Kidney Injury; Coronary Angiography; Creatinine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Poloxalene; Surface-Active Agents; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vascular Patency; Ventricular Function, Left | 1997 |
Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study Group.
Topics: Acute Kidney Injury; Coronary Circulation; Electrocardiography; Fibrinolytic Agents; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney Function Tests; Myocardial Infarction; Poloxalene; Stroke Volume; Treatment Failure; Treatment Outcome; Ventricular Function, Left | 1998 |